Jonathan Solomon
Chief Executive Officer bij BIOMX INC.
Vermogen: 11 250 $ op 31-03-2024
Profiel
Jonathan Eithan Solomon is the founder.
He founded Proclara Biosciences, Inc. in 2006 and served as the Chief Executive Officer & Media Relations Contact in 2015.
Currently, he holds the position of Chief Executive Officer & Director at BiomX, Inc. since 2019, Chief Executive Officer & Director at BiomX Ltd.
since 2017, and Director at Solomon Holdings Ltd.
since 2009.
Previously, he worked as a Principal at Medtronic Corp.
Mr. Solomon's education includes a graduate degree from Tel-Aviv University, an undergraduate degree from The Hebrew University of Jerusalem, and an MBA from Harvard Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIOMX INC.
0.05% | 11-12-2023 | 25 000 ( 0.05% ) | 11 250 $ | 31-03-2024 |
Actieve functies van Jonathan Solomon
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOMX INC. | Chief Executive Officer | 28-10-2019 |
Solomon Holdings Ltd.
 Solomon Holdings Ltd. Real Estate DevelopmentFinance Solomon Holdings Ltd. engages in the provision of real estate services. It also initiates and executes residential construction projects, and invests in income-generating real estate properties. The company was founded on July 6, 1989 and is headquartered in Herzliya, Israel. | Director/Board Member | 07-03-2013 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Chief Executive Officer | 01-05-2017 |
Eerdere bekende functies van Jonathan Solomon
| Bedrijven | Functie | Einde |
|---|---|---|
Proclara Biosciences, Inc.
 Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Founder | 01-12-2015 |
| Medtronic Corp. | Corporate Officer/Principal | - |
Opleiding van Jonathan Solomon
| Tel-Aviv University | Graduate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOMX INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Health Technology |
Solomon Holdings Ltd.
Solomon Holdings Ltd. Real Estate DevelopmentFinance Solomon Holdings Ltd. engages in the provision of real estate services. It also initiates and executes residential construction projects, and invests in income-generating real estate properties. The company was founded on July 6, 1989 and is headquartered in Herzliya, Israel. | Finance |
| Medtronic Corp. | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
